These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15660538)

  • 21. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A general method for describing sources of variance in clinical trials, especially operator variance, in order to improve transfer of research knowledge to practice.
    Chambers DW; Leknius C; Reid L
    J Prosthodont; 2009 Apr; 18(3):265-71. PubMed ID: 19141049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 24. Missing data: an introductory conceptual overview for the novice researcher.
    El-Masri MM; Fox-Wasylyshyn SM
    Can J Nurs Res; 2005 Dec; 37(4):156-71. PubMed ID: 16541824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evidence based surgery: ethical and methodological aspects].
    Kinnaert P
    Rev Med Brux; 2006; 27(5):451-8. PubMed ID: 17144645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Best (but oft-forgotten) practices: identifying and accounting for regression to the mean in nutrition and obesity research.
    Thomas DM; Clark N; Turner D; Siu C; Halliday TM; Hannon BA; Kahathuduwa CN; Kroeger CM; Zoh R; Allison DB
    Am J Clin Nutr; 2020 Feb; 111(2):256-265. PubMed ID: 31552422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multilevel analysis of group-randomized trials with binary outcomes.
    Kim HY; Preisser JS; Rozier RG; Valiyaparambil JV
    Community Dent Oral Epidemiol; 2006 Aug; 34(4):241-51. PubMed ID: 16856945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing model diagnostics.
    Karlsson MO; Savic RM
    Clin Pharmacol Ther; 2007 Jul; 82(1):17-20. PubMed ID: 17571070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the treatment effect explained by markers in the presence of measurement error.
    Sarkar S; Qu Y
    Stat Med; 2007 Apr; 26(9):1955-63. PubMed ID: 16981176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints.
    Sertdemir Y; Burgut R
    Contemp Clin Trials; 2009 Jan; 30(1):8-12. PubMed ID: 18809512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression to the mean: what it is and how to deal with it.
    Barnett AG; van der Pols JC; Dobson AJ
    Int J Epidemiol; 2005 Feb; 34(1):215-20. PubMed ID: 15333621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on measurement error on tests of statistical significance.
    Charter RA
    J Clin Exp Neuropsychol; 1997 Jun; 19(3):458-62. PubMed ID: 9268818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A primer on measures of treatment effectiveness and diagnostic test performance.
    Katz DA
    WMJ; 1999; 98(2):37-43. PubMed ID: 10235061
    [No Abstract]   [Full Text] [Related]  

  • 38. Clarifying the role of mean centring in multicollinearity of interaction effects.
    Shieh G
    Br J Math Stat Psychol; 2011 Nov; 64(3):462-77. PubMed ID: 21973096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appraising the evidence.
    Gross R; Keller DR
    WMJ; 1999; 98(2):44-8. PubMed ID: 10235062
    [No Abstract]   [Full Text] [Related]  

  • 40. Regression to the mean. A threat to exercise science?
    Shephard RJ
    Sports Med; 2003; 33(8):575-84. PubMed ID: 12797839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.